Physician profile
Amanda Lee
NPI 1871572453
$7,256.64
in general payments reported to CMS, 2019-2025
6 companies · $358 in 2025
The $358 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $75.02 · 2021: $1,557 · 2022: $125 · 2023: $2,706 · 2024: $2,286 · 2025: $358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,913 · Food and Beverage: $1,306 · Entertainment: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,912.51 |
| Food and Beverage | $1,305.65 |
| Entertainment | $132.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,258.71 | 2021-2025 | Dailies Aqua Comfort Plus, Air Optix, Dailies Total1 Multifocal |
| Coopervision INC. | $2,224.20 | 2019-2025 | Cvi Contact Lens, Misight Contact Lens |
| Allergan, INC. | $1,302.46 | 2021 | |
| Maculogix, INC. | $318.22 | 2019-2021 | |
| Optos, INC. | $132.06 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| E.R. Squibb & Sons, L.L.C. | $20.99 | 2025 | Cobenfy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.